InvestorsHub Logo
Followers 63
Posts 4216
Boards Moderated 0
Alias Born 05/25/2021

Re: whosleftholdindabag post# 434

Saturday, 09/16/2023 7:03:04 PM

Saturday, September 16, 2023 7:03:04 PM

Post# of 550
It is really the time to reconsider your investment in NVCR. It is so simple: Download the paper and consult several best experts on immunotherapy to seek their opinions.

Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients

https://doi.org/10.21203/rs.3.rs-3287211/v1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVCR News